Details for Patent: 5,508,020

Summary for Patent: 5,508,020

Title:	Technetium-99M labeled peptides for imaging
Abstract:	This invention relates to radiolabeled peptides and methods for producing such peptides. Specifically, the invention relates to peptides, methods and kits for making such peptides, and methods for using such peptides to image sites in a mammalian body labeled with technetium-99m (Tc-99m) via Tc-99m binding moieties. In particular, the peptide reagents of the invention are covalently linked to a polyvalent linker moiety, so that the polyvalent linker moiety is covalently linked to a multiplicity of the specific-binding peptides, and the Tc-99m binding moieties are covalently linked to a plurality of the specific-binding peptides, the polyvalent linker moiety, or to both the specific-binding peptides and the polyvalent linker moiety.
Inventor(s):	Dean; Richard T. (Bedford, NH), Lister-James; John (Bedford, NH)
Assignee:	Diatech, Inc. (Londonderry, NH)
Application Number:	07/893,981
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 5,508,020

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 5,508,020

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	152918
Austria	222264
Australia	4528793
Australia	5402694
Australia	688264
Australia	696206
Canada	2137009